![](https://d3ilqtpdwi981i.cloudfront.net/E2HQCgT6SUhYTTQTpvULt28Rt10=/0x45:371x523/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/b0/28/a8/b028a86d-6d53-44b9-9060-d04ab71a00e6/BHSF%20Pineapple%20Logo%20%28Imported%20Works%29.png)
Article
Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?
Journal of gastrointestinal oncology
(2017)
Disciplines
Publication Date
August 1, 2017
DOI
10.21037/JGO.2017.06.14
Citation Information
Irene Giacomelli, Daniele Scartoni, Homan Mohammadi, William F. Regine, et al.. "Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?" Journal of gastrointestinal oncology Vol. 8 Iss. 4 (2017) p. 721 - 727 Available at: http://works.bepress.com/michael-chuong/138/